The efficacy and safety of degarelix: a 12-month, comparative, randomized, open-label, parallel-group phase III study in patients with prostate cancer | BJU International | 2008 | 402 |
Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: analysis of over 4000 cycles | Human Reproduction | 2010 | 358 |
The mechanism of action for hyaluronic acid treatment in the osteoarthritic knee: a systematic review | BMC Musculoskeletal Disorders | 2015 | 200 |
Nasal administration of opioids for pain management in adults | Acta Anaesthesiologica Scandinavica | 2002 | 196 |
Exploring the ocean for new drug developments: Marine pharmacology | Journal of Pharmacy and Bioallied Sciences | 2016 | 194 |
Cardiovascular morbidity associated with gonadotropin releasing hormone agonists and an antagonist | European Urology | 2014 | 191 |
Once-daily budesonide MMX in active, mild-to-moderate ulcerative colitis: results from the randomised CORE II study | Gut | 2014 | 173 |
Quantifying observational evidence for risk of fatal and nonfatal cardiovascular disease following androgen deprivation therapy for prostate cancer: a meta-analysis | European Urology | 2015 | 168 |
Fecal microbiota manipulation prevents dysbiosis and alcohol-induced liver injury in mice | Journal of Hepatology | 2017 | 167 |
Converging goals of treatment of inflammatory bowel disease from clinical trials and practice | Gastroenterology | 2015 | 162 |
Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: a randomized trial | Hepatology | 2008 | 157 |
Endocrine profile in serum and follicular fluid differs after ovarian stimulation with HP-hMG or recombinant FSH in IVF patients | Human Reproduction | 2007 | 143 |
Inhibition of uterine contractions of premature labour with an oxytocin analogue. Results from a pilot study | BJOG: an International Journal of Obstetrics and Gynaecology | 1987 | 138 |
Individualized versus conventional ovarian stimulation for in vitro fertilization: a multicenter, randomized, controlled, assessor-blinded, phase 3 noninferiority trial | Fertility and Sterility | 2017 | 135 |
Assessing ovarian response: antral follicle count versus anti-Müllerian hormone | Reproductive BioMedicine Online | 2015 | 135 |
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis patients | Fertility and Sterility | 2013 | 119 |
Desmopressin 30 years in clinical use: a safety review | Current Drug Safety | 2007 | 116 |
Ovarian response to recombinant human follicle-stimulating hormone: a randomized, antimüllerian hormone-stratified, dose-response trial in women undergoing in vitro fertilization/intracytoplasmic sperm injection | Fertility and Sterility | 2014 | 109 |
A phase III extension trial with a 1-arm crossover from leuprolide to degarelix: comparison of gonadotropin-releasing hormone agonist and antagonist effect on prostate cancer | Journal of Urology | 2011 | 105 |
Degarelix: a novel gonadotropin-releasing hormone (GnRH) receptor blocker--results from a 1-yr, multicentre, randomised, phase 2 dosage-finding study in the treatment of prostate cancer | European Urology | 2008 | 103 |
Association between blastocyst morphology and outcome of single-blastocyst transfer | Reproductive BioMedicine Online | 2013 | 101 |
Additional analysis of the secondary end point of biochemical recurrence rate in a phase 3 trial (CS21) comparing degarelix 80 mg versus leuprolide in prostate cancer patients segmented by baseline characteristics | European Urology | 2010 | 101 |
Influence of ovarian stimulation with HP-hMG or recombinant FSH on embryo quality parameters in patients undergoing IVF | Human Reproduction | 2007 | 101 |
Gender difference in antidiuretic response to desmopressin | American Journal of Physiology - Renal Physiology | 2011 | 98 |
The physiological and pathophysiological functions of renal and extrarenal vasopressin V2 receptors | American Journal of Physiology - Renal Physiology | 2014 | 97 |